Joeri MAX SRL
The score of Joeri MAX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Joeri MAX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jun 2025
Joeri MAX's financial analysis
- Solvency70.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Joeri MAX
Joeri MAX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1010.154.931
- VAT number
- BE1010154931
- Peppol
- Registered · 0208:1010154931 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jun 2024
- Registered office
- 3990 Peer
- Latest accounts
- 2025 · filed on 20 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Joeri MAX (SRL) has been based in Peer since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 51,018 € and equity of 65,156 €; its revenue is not published. Its solvency stands at 70.5%, above the median of its sector (44.2%).
Companies similar to Joeri MAX
Companies in the same business, of comparable size and area, outside its group.
- OSLM Retail sale of pharmaceutical products Charleroi · balance sheet 92,150 €
- LEDA Pharma Retail sale of pharmaceutical products Bierbeek · balance sheet 91,792 €
- RP Pharma Retail sale of pharmaceutical products Beersel · balance sheet 91,576 €
- Arthur Pharma Retail sale of pharmaceutical products Zaventem · balance sheet 93,827 €
- Apotheker Buyse Charlotte Retail sale of pharmaceutical products Aalter · balance sheet 90,642 €
- Travel Pharma Retail sale of pharmaceutical products Oudenaarde · balance sheet 90,536 €
- Farmarie Retail sale of pharmaceutical products Destelbergen · balance sheet 94,659 €
- J. Veys Pharma Retail sale of pharmaceutical products Waregem · balance sheet 94,994 €
Frequently asked questions about Joeri MAX
What is the revenue of Joeri MAX?
Joeri MAX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Joeri MAX?
In Belgium, the VAT number is the company number prefixed with BE: BE1010154931 for Joeri MAX, if the company is VAT-registered. Its company number (CBE) is 1010.154.931.
Where is the registered office of Joeri MAX?
According to the CBE register, the registered office of Joeri MAX is in 3990 Peer.
What is the equity of Joeri MAX?
At the close of the 2025 financial year, the equity of Joeri MAX amounts to 65,156 €, a solvency of 70.5% of total assets.
Who manages Joeri MAX?
The register lists 1 active mandates at Joeri MAX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Joeri MAX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →